Getting started with Zepbound: the basics Zepbound ( tirzepatide ) is a once-weekly injectable medication that is approved by the US Food and Drug Administration (FDA) to treat obesity and overweight, as well as obstructive sleep apnea (OSA) in people with obesity
Metabolic Pathway Insights Genetic testing identifies issues in crucial pathways such as methylation, detoxification, oxidative stress, insulin sensitivity, inflammation, and lipid metabolism
Did you know that our guts affect nearly every system in the body
Jastreboff, et al., 'Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA', Lancet , vol
IGF-1 LR3 Ipamorelin Sermorelin Our specialists respond within minutes to any order or product inquiry